Cabug, Elvie M.
HRN: 10-41-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2022
CEFUROXIME 500MG (TAB)
11/09/2022
11/15/2022
PO
500 Mg
BID
S/p Rmle
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes